Estimates of maximum tolerable levels of tyramine content in foods in Austria

Journal of Food and Nutrition Research

Volumn 51, Issue 1, 2012, Pages 52-59

  Paulsen, Peter ^a   Grossgut, Roland ^b   Bauer, Friedrich ^a   Rauscher Gabernig, Elke ^b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

Author keywords

"No observed adverse effect level"; Exposure assessment; Tolerable content; Tyramine

Indexed keywords

EID: 84857809121     PISSN: 13368672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Beutling, D. M.: Biogene Amine in der Ernährung. Wien, Berlin, New York: Springer, 1996. 265 pp.ISBN 3-540-60398-0.
2. Pötzelberger, D., Paulsen, P., Hellwig, E., Bauer, F.: Investigations on shelf life and shelf life assessment of raw meat: formation of biogenic amines and microbial changes during storage. Fleischwirtschaft, 78, 1998, pp. 796-797.
3. Suzzi, G., Gardini, F.: Biogenic amines in dry fermented sausages: a review. International Journal of Food Microbiology, 88, 2003, pp. 41-54.
4. Vinci, G., Antonelli, M. L.: Biogenic amines: quality index of freshness in red and white meat. Food Control, 13, 2003, pp. 519-524
5. Bauer, F., Paulsen, P.: Biogenic amines in meat and meat products. In: Morgan, D. M. L., Milovic, V., Krizek, M., White, A. (Ed.): COST 917, Biogenically active amines in food. Vol. 5. Luxembourg: Office for Official Publications in the EU, 2001, pp. 88-93.
6. Paulsen P., Hagen, U., Bauer, F.: Changes in biogenic amine contents, non protein nitrogen and crude protein during curing and thermal processing of M. longissimus, pars lumborum of pork. European Food Research and Technology, 223, 2006, pp. 603-608.
7. Pircher, A., Bauer, F., Paulsen, P.: Formation of cadaverine, histamine, putrescine and tyramine by bacteria isolated from meat, fermented sausages and cheeses. European Food Research and Technology, 226, 2007, pp. 225-231.
8. Özogul, F., Özogul, Y.: The ability of biogenic amines and ammonia production by single bacterial cultures. European Food Research and Technology, 225, 2007, pp. 385-394.
9. Marino, M., Maifreni, M., Moret, S., Rondinini, G.: The capacity of Enterobacteriaceae species to produce biogenic amines in cheese. Letters in Applied Microbiology, 31, 2000, pp. 169-173.
10. Bunkova, L., Bunkova, F., Hlobilova, M., Vanatkova, Z., Novakova, D., Drab, V.: Tyramine production of technological important strains of Lactobacillus, Lactococcus and Streptococcus. European Food Research and Technology, 229, 2009, pp. 533-538.
11. Latorre-Moratalla, M. L., Bover-Cid, S., Talon, R., Garriga, M., Zanardi, E., Ianieri, A, Fraqueza, M. J., Elias, M., Drosinos, E. H., Vidal- Carou, M. C.: Strategies to reduce biogenic amine accumulation in traditional sausage manufacturing. LWT, Food Science and Technology, 43, 2010, pp. 20-25.
12. Walker, S. E., Shulman, K. I., Tailor, S. A. N, Gardner, D.: Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets. Journal of Clinical Psychopharmacology, 16, 1996, pp. 383-389.
13. McCabe-Sellers, B. J., Staggs, C. G., Bogle, M. L.: Tyramine in foods and monoamino oxidase inhibitor drugs: A crossroad where medicine, nutrition, pharmacy and food industry converge. Journal of Food Composition and Analysis, 19, 2006, pp. S58-S65.
14. Scientific opinion on risk based control of biogenic amine formation in fermented foods. EFSA Journal, 9, 2011, pp. 1-93.
15. Bover-Cid, S., Latorre-Moratella, M., Veciana- Noguez, T., Vidal-Carou, C.: Assessment of consumer exposure to tyramine from fermented sausages. In: Food Micro 2008. Evolving microbial food quality and safety, Aberdeen, Scotland, 1-4 September 2008 [online]. Aberdeen: The International Committee on Food Microbiology and Hygiene, 2008 [cited 3 October 2011]. http://aberdeen.conference-services.net/resources/374/1143/pdf/FM2008_0265.pd
16. Davey, M. J., Farmer, J. B.: The mode of action of tyramine. Journal of Pharmacy and Pharmacology, 15, 1963, pp. 178-182.
17. Da Prada, M., Zurcher, G., Wuthrich, I.: On tyramine, food, beverages: the reversible MAO in hibitor moclobemide. Journal of Neural Transmission, 26, 1988, pp. 31-36.
18. Perry, T. L., Hestrin, M., McDougall, L, Hansen, S.: Urinary amines of intestinal bacterial origin. Clinica Chimica Acta, 14, 1966, pp. 116-123.
19. Price, K., Smith, S. E.: Cheese reaction and tyramine. Lancet, 297, 1971, pp. 130-131.
20. Fankhauser, C., Charieras, T., Caille, D, Rovei, V.: Interaction of MAO inhibitors and dietary amine: a new experimental model in the conscious rat. Journal of Pharmacological and Toxicological Methods, 32, 1994, pp. 219-224.
21. Livingston, M. G., Livingston, H. M.: Monoamine oxidase inhibitor: an update on drug interactions. Drug Safety, 14, 1996, pp. 219-227.
22. Anderson, K. E.: Effects of specific foods and dietary components on drug metabolism, tyramine and related substances. In: Boullata, J. I, Armenti, V. T. (Ed.): Handbook of drug-nutrient interactions. 2nd ed. New York: Humana Press, 2010, pp. 254-256.
23. Ghose, K.: Assessment of peripherial adrenergic activity and its interaction with drugs in man. European Journal of Clinical Pharmacology, 17,1980, pp. 233-238.
24. Ghose, K.: Tyramine pressor test: implications and limitations. Methods and Findings in Experimental and Clinical Pharmacology, 6, 1984, pp. 455-464.
25. Schulz, R., Bieck, P. R.: Oral tyramine test and the safety of MAO inhibitor drugs. Psychopharmacology, 91, 1987, pp. 515-516.
26. Hanington, E.: Preliminary report on tyramine headache. British Medical Journal, 5551, 1967, pp. 550-551.
27. Schmidt, J.: Grundlagen der Pharmakotherapie der allergischen Rhinitis mit Radethazin® (Azelastin). Medicamentum, H7, 1992, pp. 193-197.
28. Mosnaim, A. D., Frietag, F. G., Ignacia, R., Salas, M. A., Karoum, F., Wolf, M. E, Diamond, S.: Apparent lack of correlation between tyramine and phenylethylamine content and the occurrence of food precipitated migraine: re-examination of a variety of food products frequently consumed in the United States and commonly restricted in tyramine-restricted diets. Headache Quarterly, 7, 1996, pp. 239-249.
29. Peatfield, R., Littlewood, J. T., Glover, V, Sandler, M., Rose, F. C.: Pressor sensitivity to tyramine in patients with headache: relationship to platelet monoamino oxidase and to dietary provocation. Journal of Neurology, Neurosurgery and Psychiatry, 46, 1983, pp. 827-831.
30. Barolin, G. S.: Kopfschmerz aus klinisch-neurologischer Sicht. In: Beutling, D. (Ed.): Biogene Amine in der Ernährung. Berlin, Heidelberg, New York: Springer, 1996, pp. 202-211.
31. Holzhammer, J., Wöber, C.: Alimentäre Triggerfaktoren bei Migräne und Kopfschmerz vom Spannungstyp. Schmerz, 20, 2006, pp. 151-159.
32. Korn, A., Da Prada, M., Raffesberg, W., Allen, S, Gasic, S.: Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor. Journal of Neural Transmission Supplement, 26, 1988, pp. 57-71.
33. Korn, A., Da Prada, M., Raffesberg, W, Gasic, S., Eichler, H. G.: Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressure effect of tyramine. Journal of Cardiovascular Pharmacology, 11, 1988, pp. 17-23.
34. Audebert, C., Blint, O., Monjanel-Mouterde, S, Auquier, P., Pedarriosse, A. M., Dingemanse, J, Durand, A., Canot, J. P.: Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers. European Journal of Clinical Pharmacology, 43, 1992, pp. 507-512.
35. Azzaro, A. J., Van den Berg, C. M, Blob, L. F., Kemper, E. M., Sharoky, M, Oren, D. A., Campbell, B. J.: Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg / 24 h in healthy subjects. Journal of Clinical Pharmacology, 46, 2006, pp. 933-944.
36. Van den Bergh, C. M., Blob, L. F., Kemper, E. M., Azzaro, A. J.: Tyramine pharmacokinetics and reduced bioavailability with food. Journal of Clinical Pharmacology, 43, 2003, pp. 604-609.
37. Simpson, G. M., Gratz, S. S.: Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers. Clinical Pharmacology and Therapeutics, 52, 1992, pp. 286-291.
38. Bütikofer, U., Fuchs, D.: Development of free amino acids in Appenzeller, Emmentaler, Gruyère, Raclette, Sbrinz and Tilsiter cheese. Lait, 77, 1997, pp. 91-100.
39. Pfannhauser, W., Pechanek, U.: Biogene Amine in Lebensmitteln. Bildung, Vorkommen, Analytik und toxikologische Bewertung. Zeitschrift für die gesamte Hygiene, 30, 1984, pp. 66-76.
40. Kalac, P., Spicka, J., Krizek, M, Steidlova, S., Pelikanova, T.: Concentrations of seven biogenic amines in sauerkraut. Food Chemistry, 67, 1999, pp. 275-280.
41. Pons-Sanchez-Cascado, S., Veciana- Nogues, M. T., Bover-Cid, S., Marine-Font, A, Vidal-Carou, M. C.: Volatile and biogenic amines, microbiological counts, and bacterial amino acid decarboxylase activity throughout the salt-ripening process of anchovies (Engraulis encrasicholus). Journal of Food Protection, 68, 2005, pp. 1683-1689.
42. Stute, R., Petridis, K., Steinhart, H., Biernoth, G.: Biogenic amines in fish and soy sauces. European Food Research and Technology, 215, 2002, pp. 101-107.
43. Blackwell, B., Mabbitt, L. A., Marley, E.: Histamine and tyramine content of yeast products. Journal of Food Science, 34, 1969, pp. 47-51.
44. Spicka, J., Kalac, P., Bover-Cid, S., Krizek, M.: Application of lactic acid bacteria starter cultures for decreasing the biogenic amine levels in sauerkraut. European Food Research and Technology, 215, 2002, pp. 509-514.
45. Loret, S., Deloyer, P., Dandrifosse, G.: Levels of biogenic amines as a measure of the quality of the beer fermentation process: Data from Belgian samples. Food Chemistry, 89, 2005, pp. 519-525.
46. Rauscher-Gabernig, E., Grossgut, R., Bauer, F, Paulsen, P.: Assessment of alimentary histamine exposure of consumers in Austria and development of tolerable levels in typical foods. Food Control, 20, 2009, pp. 423-429.
47. Rauscher-Gabernig, E., Grossgut, R, Bauer, F., Paulsen, P.: Phenylethylamin in Lebensmitteln: Gehalte und Erarbeitung von tolerierbaren Höchstgehalten. Wiener Tierärztliche Monatsschrift / Veterinary Medicine Austria, 97, 2010, pp. 242-252.
48. Souci, S. W., Fachmann, W., Kraut, H.: Food composition and nutrition tables. 6th ed. Stuttgart: Medpharm Scientific Publishers, 2000. 1182 pp.ISBN 3-88763-076-9.
49. Bauer, F., Paulsen, P., Wasserbacher, B., Hagen, U, Ralph, A., Elmadfa, I., Bardocz, S.: The intake of biogenic amines in the diet. In: Wallace, H. M, Hughes, H. (Ed.): Health implications of biogenic amines, Vol. 1. Review of current status. Luxembourg: Office for Official publications in the EU, 2004, pp. 34-41.
50. Lüthy, J., Schlatter, C.: Biogene Amine in Lebensmitteln: Zur Wirkung von Histamin, Tyramin und Phenylethylamin auf den Menschen. Zeitschrift für Lebensmitteluntersuchung und -Forschung, 177, 1993, pp. 439-443.
51. Hanington, E., Harper, A. M.: The role of tyramine in the aetiology of migraine, and related studies on the cerebral and extracerebral circulations. Headache, 8, 1968, pp. 84-97.
52. Grind, M., Siwers, B., Graffner, C., Alvan, G, Gustafsson, L. L., Halliday, J., Lingren, J. E, Ogenstad, S., Selander, H.: Pressure response of oral tyramine in healthy man given amiflamin and placebo. Clinical Pharmacology and Therapeutics, 40, 1986, pp. 155-160.
53. Bieck, P. R., Antonin, K. H.: Oral tyramine pressor test and the safety of monoamino oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects. Journal of Clinical Psychopharmacology, 8, 1988, pp. 237-245.
54. Elsworth, J. D., Glover, V., Reynolds, G. P, Sandler, M., Lees, A. J., Phuapradit, P., Shaw, K. M, Stern, G. M., Kumar, P.: Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the cheese effect. Psychopharmacology (Berlin), 57, 1978, pp. 33-38.
55. Schulz, R., Antonin, K. H., Hoffmann, E, Jedrychowski, M., Nilsson, E., Schick, C, Bieck, P. R.: Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline. Clinical Pharmacology and Therapeutics, 46, 1989, pp. 528-536.
56. Patkar, A. A., Pae, C. U., Zarzar, M.: Transdermal selegiline. Drugs of Today, 43, 2007, pp. 361-377.